Ultima Genomics’ UG200 Platform will support an 80,000-sample UK Biobank immune profiling study with IMU Biosciences.

The Hall of Fame honour follows six consecutive appearances by Dr Kalebi on The Pathologist Power List, in 2019, 2020, 2021, ...

Researchers at Heidelberg University Hospital have developed a PBMC-based proof-of-principle framework for fit-for-purpose ...

Self-developed bead-based multiplex detection solves critical bottlenecks of limited sample volume and low throughput ...

A large Chinese cohort study shows that lymphocyte subsets in women undergo a pronounced reconfiguration around menopause, ...

In patients with R/R B-ALL who underwent HSCT, researchers compared outcomes between those who received InO during ...

A Sovereign AI grant backs the first 10,000 samples of an IMU Biosciences and UK Biobank project to link immune-cell profiles with genetics and health records.

Individual-cell imaging, super intelligence and sire tracking are bringing a new level of detail to semen evaluation at Iowa ...

Kenyan pathologist Dr Ahmed Kalebi has been inducted into the inaugural Hall of Fame of The Pathologist, becoming the only African and the only representative from a low- or middle-income country ...

A medication already used to treat diabetes may protect the heart by changing how immune cells behave in the bloodstream. In ...

Founded by leading experimental immunologists and computational biologists with over a decade of systems immunology expertise, IMU combines deep immune profiling from small blood samples with ...

IMU Biosciences will work with UK Biobank to analyze 80,000 blood samples and generate large-scale data on participants' immune systems, the company said on Monday. The company said the project will ...